vs
Monte Rosa Therapeutics, Inc.（GLUE）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
RIVERVIEW BANCORP INC的季度营收约是Monte Rosa Therapeutics, Inc.的1.1倍（$14.0M vs $12.8M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -212.1%，领先221.9%），Monte Rosa Therapeutics, Inc.同比增速更快（38.5% vs 10.4%），Monte Rosa Therapeutics, Inc.自由现金流更多（$99.8M vs $-736.0K）
Monte Rosa Therapeutics是一家临床阶段生物技术企业，专注于研发靶向分子胶降解剂疗法，管线覆盖肿瘤、罕见遗传病及免疫疾病领域的未满足医疗需求，通过自主研发与行业合作推进创新疗法惠及全球患者。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
GLUE vs RVSB — 直观对比
营收规模更大
RVSB
是对方的1.1倍
$12.8M
营收增速更快
GLUE
高出28.2%
10.4%
净利率更高
RVSB
高出221.9%
-212.1%
自由现金流更多
GLUE
多$100.5M
$-736.0K
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $12.8M | $14.0M |
| 净利润 | $-27.1M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -258.3% | 12.4% |
| 净利率 | -212.1% | 9.8% |
| 营收同比 | 38.5% | 10.4% |
| 净利润同比 | -13.5% | 11.8% |
| 每股收益（稀释后） | — | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLUERVSB
| Q4 25 | — | $14.0M | ||
| Q3 25 | $12.8M | $13.6M | ||
| Q2 25 | $23.2M | $13.3M | ||
| Q1 25 | $84.9M | $12.9M | ||
| Q4 24 | $60.6M | $12.7M | ||
| Q3 24 | — | $12.8M | ||
| Q2 24 | — | $12.2M | ||
| Q1 24 | — | $9.0M |
净利润GLUERVSB
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-27.1M | $1.1M | ||
| Q2 25 | $-12.3M | $1.2M | ||
| Q1 25 | $46.9M | $1.1M | ||
| Q4 24 | $13.4M | $1.2M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | — | $966.0K | ||
| Q1 24 | — | $-3.0M |
营业利润率GLUERVSB
| Q4 25 | — | 12.4% | ||
| Q3 25 | -258.3% | 10.2% | ||
| Q2 25 | -67.1% | 11.7% | ||
| Q1 25 | 51.9% | 11.3% | ||
| Q4 24 | 21.4% | 12.4% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 10.0% | ||
| Q1 24 | — | -47.5% |
净利率GLUERVSB
| Q4 25 | — | 9.8% | ||
| Q3 25 | -212.1% | 8.1% | ||
| Q2 25 | -53.0% | 9.2% | ||
| Q1 25 | 55.2% | 8.9% | ||
| Q4 24 | 22.2% | 9.7% | ||
| Q3 24 | — | 12.2% | ||
| Q2 24 | — | 7.9% | ||
| Q1 24 | — | -34.7% |
每股收益（稀释后）GLUERVSB
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.3M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.8M | $164.2M |
| 总资产 | $459.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GLUERVSB
| Q4 25 | — | $28.6M | ||
| Q3 25 | $208.3M | $32.8M | ||
| Q2 25 | $69.4M | $34.2M | ||
| Q1 25 | $78.5M | $29.4M | ||
| Q4 24 | $224.3M | $25.3M | ||
| Q3 24 | — | $31.0M | ||
| Q2 24 | — | $27.8M | ||
| Q1 24 | — | $23.6M |
股东权益GLUERVSB
| Q4 25 | — | $164.2M | ||
| Q3 25 | $245.8M | $163.5M | ||
| Q2 25 | $268.1M | $162.0M | ||
| Q1 25 | $275.2M | $160.0M | ||
| Q4 24 | $222.9M | $158.3M | ||
| Q3 24 | — | $160.8M | ||
| Q2 24 | — | $155.9M | ||
| Q1 24 | — | $155.6M |
总资产GLUERVSB
| Q4 25 | — | $1.5B | ||
| Q3 25 | $459.8M | $1.5B | ||
| Q2 25 | $359.6M | $1.5B | ||
| Q1 25 | $393.2M | $1.5B | ||
| Q4 24 | $438.7M | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $100.4M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $99.8M | $-736.0K |
| 自由现金流率自由现金流/营收 | 781.5% | -5.2% |
| 资本支出强度资本支出/营收 | 5.1% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $145.0M | $20.4M |
8季度趋势，按日历期对齐
经营现金流GLUERVSB
| Q4 25 | — | $-506.0K | ||
| Q3 25 | $100.4M | $16.8M | ||
| Q2 25 | $-34.7M | $-697.0K | ||
| Q1 25 | $-45.5M | $8.3M | ||
| Q4 24 | $128.9M | $2.2M | ||
| Q3 24 | — | $764.0K | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | — | $12.8M |
自由现金流GLUERVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | $99.8M | $16.4M | ||
| Q2 25 | $-36.4M | $-773.0K | ||
| Q1 25 | $-47.1M | $5.6M | ||
| Q4 24 | $128.7M | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率GLUERVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | 781.5% | 120.1% | ||
| Q2 25 | -157.0% | -5.8% | ||
| Q1 25 | -55.4% | 43.1% | ||
| Q4 24 | 212.3% | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度GLUERVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | 5.1% | 2.9% | ||
| Q2 25 | 7.3% | 0.6% | ||
| Q1 25 | 1.9% | 21.0% | ||
| Q4 24 | 0.3% | 2.4% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 62.0% |
现金转化率GLUERVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | -0.97× | 7.20× | ||
| Q4 24 | 9.59× | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
